CA Botana International recalled 1,401 tubes of Doctor D. Schwab Flawless Skin Fluid Tinted Moisturizer on October 10, 2025. The product may not meet current Good Manufacturing Practices (CGMP). Consumers should stop using it immediately and contact the company for guidance.
CGMP Deviations
Consumers and healthcare providers should stop using this product immediately. Contact CA BOTANA International, Inc. or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is Doctor D. Schwab Flawless Skin Fluid Tinted Moisturizer SPF 50, containing 21% Zinc Oxide. It comes in a 2.1 oz tube with Lot Code D54757 and an expiration date of March 31, 2028. Distribution occurred in California, Colorado, Florida, Puerto Rico, and Washington.
The recall stems from deviations from current Good Manufacturing Practices, which could affect product safety and effectiveness. Consumers should be cautious as improper manufacturing can lead to contamination or reduced efficacy.
No incidents or injuries have been reported related to this recall. The nature of the CGMP deviations raises potential safety concerns.
Stop using the product immediately. Contact CA Botana International, Inc. or your healthcare provider for further guidance. A notification letter will be sent to consumers.
For more information, contact CA Botana International at [contact number]. Visit the FDA website for additional details.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.